Novartis researchers are learning how a novel approach to immunotherapy could help treat cancer.
Learn about the career of our Global Medical Affairs Head for Solid Tumors and Rare Diseases.
Novartis is committed to transforming the lives of people living with blood cancers and serious blood disorders.
A Cell & Gene production unit staffed by a highly trained team at Novartis will soon begin operating in Stein, Switzerland.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.
This site is intended for a global audience.